Description

3-Oxo-3,4-Dihydro-2H-Pyrido[3,2-B][1,4]Oxazine-6-Carboxylic Acid is a high-purity, advanced pharmaceutical intermediate of significant importance in modern drug discovery and development. This heterocyclic carboxylic acid derivative serves as a critical building block for synthesizing novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring complex molecular architectures. It is primarily sought after by research institutions and pharmaceutical manufacturers engaged in the development of innovative small-molecule drugs.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates targeting various disease pathways.
• Organic Synthesis Building Block: Used in medicinal chemistry for constructing complex heterocyclic scaffolds with potential biological activity.
• Research & Development (R&D): Essential for academic and industrial research programs focused on new chemical entities (NCEs) and structure-activity relationship (SAR) studies.
• API Synthesis: Employed in the multi-step synthesis of potential Active Pharmaceutical Ingredients (APIs), especially in oncology and central nervous system (CNS) therapeutic areas.
• Chemical Reference Standard: Serves as a high-purity standard for analytical method development and quality control in pharmaceutical manufacturing.

Basic Information

Product Name	3-Oxo-3,4-Dihydro-2H-Pyrido[3,2-B][1,4]Oxazine-6-Carboxylic Acid
CAS No.	337463-89-5
Molecular Formula	C9H6N2O4
Molecular Weight	206.16 g/mol
Synonyms	3-Oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine-6-carboxylic acid; 2H-Pyrido[3,2-b][1,4]oxazine-6-carboxylic acid, 3,4-dihydro-3-oxo-; 337463-89-5; Pyrido[3,2-b][1,4]oxazine-6-carboxylic acid derivative; 6-Carboxy-3-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine
EINECS	Contact for details

Quality Control

Our 3-Oxo-3,4-Dihydro-2H-Pyrido[3,2-B][1,4]Oxazine-6-Carboxylic Acid is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D and synthesis. A comprehensive Certificate of Analysis (COA) detailing purity, assay, and impurity profiles is provided with each shipment to guarantee traceability and consistency.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). The product should be kept under an inert atmosphere if long-term storage is required to prevent potential degradation.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.